Revenue Components (Tables)

6 Months Ended

Sep. 30, 2021

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

The following table provides information about the Company’s revenues for the three and six months ended September 30, 2021 and 2020 (in thousands):

	Three Months Ended September 30,				Six Months Ended September 30,
	2021		2020		2021		2020
Revenues:
Product revenue, net:
ORGOVYX	$	18,663	$	—	$	29,142	$	—
MYFEMBREE	629		—		1,704		—
Richter product supply and royalties	1,771		—		1,771		—
Total product revenue, net	21,063		—		32,617		—
Pfizer collaboration revenue:
Amortization of upfront payment	20,974		—		41,948		—
Amortization of regulatory milestone	4,198		—		12,733		—
Total Pfizer collaboration revenue	25,172		—		54,681		—
Richter license and milestone revenue	31,667		—		31,667		33,333
Total revenues	$	77,902	$	—	$	118,965	$	33,333